Company Shanghai Haohai Biological Technology Co., Ltd.

Equities

6826

CNE100001W69

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Shanghai Haohai Biological Technology Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

Delayed Hong Kong S.E. Other stock markets 11:53:18 2024-04-23 pm EDT			5-day change	1st Jan Change
38.6 ^HKD	+0.78%		+1.18%	-4.22%

Mar. 11	Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%	MT
Feb. 23	Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.

Number of employees: 2,158

HKD in Million	2022	Weight	2023	Weight	Delta
Medical Aesthetics and Wound Care 40.0 %	870	35.1 %	1,173	40.0 %	+34.83%
Ophthalmic 35.0 %	895	36.1 %	1,026	35.0 %	+14.57%
Orthopedic 17.9 %	452	18.2 %	526	17.9 %	+16.46%
Anti-Adhesion and Hemostatic 5.3 %	206	8.3 %	157	5.3 %	-23.97%
Other 1.7 %	54	2.2 %	51	1.7 %	-5.49%

HKD in Million	2022	Weight	2023	Weight	Delta
China 82.9 %	2,007	81.0 %	2,432	82.9 %	+21.18%
Other Countries 7.4 %	186	7.5 %	217	7.4 %	+16.98%
Europe 5.1 %	164	6.6 %	150	5.1 %	-8.19%
United States 4.5 %	121	4.9 %	133	4.5 %	+10.19%

Managers	Title	Age	Since
Jian Ying Wu CEO	Chief Executive Officer	60	07-06-30
Min Jie Tang DFI	Director of Finance/CFO	49	16-07-31
Chang Zheng Wei CTO	Chief Tech/Sci/R&D Officer	45	09-09-30
Min Tian IRC	Investor Relations Contact	35	15-06-30
Cai Xia Ren PRN	Corporate Officer/Principal	67	07-06-30

Members of the board	Title	Age	Since
Yi Yi Chen BRD	Director/Board Member	42	07-01-23
Yong Tai Hou CHM	Chairman	63	07-01-23
Jian Ying Wu CEO	Chief Executive Officer	60	07-06-30
Ming Huang BRD	Director/Board Member	49	07-01-23
Jie You BRD	Director/Board Member	61	10-07-22
Yuan Zhong Liu CHM	Chairman	56	10-07-22
Yue Jun Tang BRD	Director/Board Member	46	14-10-15
Min Jie Tang DFI	Director of Finance/CFO	49	16-07-31
Zhi Su BRD	Director/Board Member	47	20-06-28
Yu She Yang BRD	Director/Board Member	61	20-06-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	140,198,089	36,097,193 ( 25.75 %)	1,089,486 ( 0.7771 %)	37.95 %
Stock B	1	32,895,100	29,587,600 ( 89.95 %)	3,296,500 ( 10.02 %)

Name	Equities	%	Valuation
Prudence Investment Management (Hong Kong) Ltd. 6.654 %	1,969,600	6.654 %	10 M $
ROYAL BANK OF CANADA 5.615 %	1,662,000	5.615 %	8 M $
Fullgoal Fund Management Co., Ltd. 5.094 %	1,507,800	5.094 %	8 M $
Kabouter Management LLC 4.997 %	1,478,989	4.997 %	8 M $
Templeton Investment Counsel LLC 4.090 %	1,210,700	4.090 %	6 M $
Dalton Investments LLC 3.904 %	1,155,400	3.904 %	6 M $
GF Fund Management Co., Ltd. 1.371 %	405,700	1.371 %	2 M $
China Southern Asset Management Co., Ltd. 0.5605 %	165,900	0.5605 %	847 893 $
Andbank Wealth Management SGIIC SAU 0.0624 %	18,461	0.0624 %	94 352 $
Min Jie Tang 0.0372 %	11,000	0.0372 %	56 220 $

Name	Equities	%	Valuation
Wei Jiang 42.12 %	49,190,000	42.12 %	670 M $
Jie You 24.66 %	28,800,000	24.66 %	393 M $
Guo Liang Lou 5.267 %	6,151,186	5.267 %	84 M $
Jian Ying Wu 5.196 %	6,068,369	5.196 %	83 M $
Yong Tai Hou 5.143 %	6,006,260	5.143 %	82 M $
Ming Huang 1.712 %	2,000,000	1.712 %	27 M $
Yuan Zhong Liu 1.712 %	2,000,000	1.712 %	27 M $
Wen Bin Wang 1.464 %	1,709,704	1.464 %	23 M $
Wanjia Asset Management Co., Ltd. 0.9953 %	1,162,412	0.9953 %	16 M $
Bosera Asset Management Co., Ltd. 0.9013 %	1,052,680	0.9013 %	14 M $

Shanghai Haohai Biological Technology Co., Ltd.

23/F, Wenguang Building No. 1386 Hongqiao Road

200336, Shanghai

+86 21 5229 3555

http://www.3healthcare.com

address Shanghai Haohai Biological Technology Co., Ltd.(6826)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

35.41 CNY

Average target price

65.08 CNY

Spread / Average Target

+83.78%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.	-4.96%	1.9B
ABBOTT LABORATORIES	-2.25%	186B
MEDTRONIC PLC	-1.32%	107B
BECTON, DICKINSON AND COMPANY	-3.92%	67.57B
DEXCOM, INC.	+7.99%	50.7B
CENCORA, INC.	+15.74%	47.2B
HOYA CORPORATION	-0.45%	39.72B
WEST PHARMACEUTICAL SERVICES, INC.	+10.81%	27.48B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.34%	25.65B
TERUMO CORPORATION	+13.37%	24.97B

Other Medical Equipment, Supplies & Distribution